IL10 and Alzheimer disease: Zhang et al. demonstrated that isoorientin decreased Aβ plaque deposition in the cortex and hippocampus of AD mice and significantly decreased TNF-α, IL-6, iNOS and COX-2 and increased IL-4 and IL-10 in AD mice [42].